French drugmaker Sanofi has agreed a potential US$2 billion deal with U.S. biotech company Translate Bio to make vaccines, expanding their collaboration in development of an inoculation against COVID-19.
Sanofi clinches US$2 billion vaccines deal with Translate Bio
